For example, non-small cell lung cancer (NSCLC) cells harboring the T790M mutations in the Epidermal Growth Factor Receptor (EGFR) are resistant to the cancer drug, gefitinib, whereas cells harboring the L858R mutation are hypersensitive to the same drug [5, 6]. The gene discussed is EGFR; the disease is cancer.